Reversal of Chemoresistance in Ovarian Cancer by Co-delivery of MDR Inhibitors and Paclitaxel Using a Targeted Liposomal Platform
The faseb journal (2015)
Institution: University of Chicago, USA
Cell Line: SKOV3 (Human ovarian cancer line)
Research Area: Cancer research
Conclusions: Using time-course holographic imaging studies, this cell cycle arrest followed by progression to apoptosis was clearly visualized and confirmed.